Ryan Michael Dauer

Ryan Dauer practices at Gastro Health in Hollywood, Florida.

Ryan Dauer's NPI, 1376938449, was assigned on April 5, 2015. Ryan Dauer graduated from University of Miami, Miller School of Medicine in 2015. Ryan Dauer holds Florida license ME149366.

Ryan Dauer's primary practice is Gastro Health, at 4700 Sheridan St, Hollywood, FL 33021 in Broward County. The practice phone is (305) 913-0666.

Ryan Dauer's primary practice is Gastro Health in Hollywood, Florida. Ryan Dauer is also affiliated with Memorial Regional Hospital. The medical group on file is Gastro Health. Dmand AI also links Ryan Dauer to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ryan Dauer practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Ryan Dauer's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Ryan Dauer is board certified in gastroenterology by the American Board of Internal Medicine. Ryan Dauer is licensed in Florida.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, gastroduodenitis, gastroenteritis, gastrointestinal bleeding, hemorrhoids and intestinal diverticulosis among the conditions Ryan Dauer treats.

CMS data shows 347 Medicare services from Ryan Dauer across 10 procedure codes in 2024, for 200 Medicare patients. Medicare paid $32,155 for them.

CMS counts 200 Medicare patients who saw Ryan Dauer in 2024. The largest group is 65 to 74, with 102 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ryan Dauer's median patient age at 55, with 55% women.

In 2024, Ryan Dauer wrote 792 Medicare Part D claims for 310 patients. 71% of them were for generic drugs. CMS names the drug for 642 of them, across 17 drugs with 11 or more claims each, at $156,406 in total drug cost. In 2023, CMS named 539 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Ryan Dauer for performance year 2024, reported as part of a group. Ryan Dauer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 44 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Ryan Dauer, more than 61% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Ryan Dauer, published from 2016 to 2024. Ryan Dauer's most frequent co-authors are Maria Teresa Abreu, MD, Oriana Mazorra Damas, MD and Amar R. Deshpande, MD.

CMS Open Payments shows 297 general payments to Ryan Dauer from 30 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $1,044.

Ryan Dauer graduated from University of Miami, Miller School of Medicine in 2015.

Ryan Dauer is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.